Lothar Mueller

2.5k total citations
52 papers, 1.6k citations indexed

About

Lothar Mueller is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Soil Science. According to data from OpenAlex, Lothar Mueller has authored 52 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 11 papers in Soil Science. Recurrent topics in Lothar Mueller's work include Colorectal Cancer Treatments and Studies (9 papers), Soil Carbon and Nitrogen Dynamics (9 papers) and Soil and Unsaturated Flow (8 papers). Lothar Mueller is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Soil Carbon and Nitrogen Dynamics (9 papers) and Soil and Unsaturated Flow (8 papers). Lothar Mueller collaborates with scholars based in Germany, Russia and China. Lothar Mueller's co-authors include Uwe Schindler, Frank Eulenstein, Axel Behrendt, B.C. Ball, Chunsheng Hu, T. Graham Shepherd, Ralf Wieland, Georg von Unold, Wolfgang Durner and Gunnar Lischeid and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

Lothar Mueller

50 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lothar Mueller Germany	23	475	358	298	251	200	52	1.6k
Richard Hammer United States	21	370 0.8×	215 0.6×	106 0.4×	249 1.0×	64 0.3×	108	1.5k
Shengping Li China	29	845 1.8×	540 1.5×	170 0.6×	121 0.5×	104 0.5×	70	2.4k
J. Blackwell Australia	22	565 1.2×	277 0.8×	222 0.7×	137 0.5×	123 0.6×	94	2.1k
M. S. Srinivasan New Zealand	26	595 1.3×	1.2k 3.2×	122 0.4×	244 1.0×	174 0.9×	58	3.3k
Rudolph S. Parrish United States	23	353 0.7×	259 0.7×	1.3k 4.3×	1.2k 4.9×	103 0.5×	58	3.5k
Alfredo Polo Spain	38	2.2k 4.6×	342 1.0×	165 0.6×	109 0.4×	673 3.4×	139	5.5k
Daoyuan Wang China	23	551 1.2×	135 0.4×	211 0.7×	67 0.3×	192 1.0×	81	1.8k
Xiubin He China	27	1.4k 3.0×	161 0.4×	375 1.3×	268 1.1×	271 1.4×	127	3.4k
Tianwei Wang China	29	896 1.9×	76 0.2×	162 0.5×	321 1.3×	62 0.3×	136	2.6k
Zhifeng Yan China	22	369 0.8×	97 0.3×	121 0.4×	195 0.8×	36 0.2×	102	2.0k

Countries citing papers authored by Lothar Mueller

Since Specialization

Citations

This map shows the geographic impact of Lothar Mueller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lothar Mueller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lothar Mueller more than expected).

Fields of papers citing papers by Lothar Mueller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lothar Mueller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lothar Mueller. The network helps show where Lothar Mueller may publish in the future.

Co-authorship network of co-authors of Lothar Mueller

This figure shows the co-authorship network connecting the top 25 collaborators of Lothar Mueller. A scholar is included among the top collaborators of Lothar Mueller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lothar Mueller. Lothar Mueller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mueller, Lothar, Charalampos Andriotis, & Michela Turrin. (2024). Data and Parameterization Requirements for 3D Generative Deep Learning Models. eCAADe proceedings. 1. 615–624.

Gerwert, Klaus, Frederik Großerueschkamp, Inke Sabine Feder, et al.. (2023). Fast and label-free automated detection of microsatellite status in early colon cancer using artificial intelligence integrated infrared imaging. European Journal of Cancer. 182. 122–131. 18 indexed citations

Heinrich, Kathrin, Meinolf Karthaus, Ullrich Graeven, et al.. (2023). Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212). ESMO Open. 8(4). 101568–101568. 6 indexed citations

Welslau, Manfred, PA Fasching, Lothar Mueller, et al.. (2023). 378O Persistence under abemaciclib and endocrine treatment (ABA+ET) in patients with advanced breast cancer (aBC): First results of the randomized IMPACT trial comparing patient coaching with the MASCC oral agent teaching tool (MOATT) versus local routine patient coaching (LC). Annals of Oncology. 34. S336–S336. 4 indexed citations

Großerüschkamp, Frederik, Christian Sternemann, Inke Sabine Feder, et al.. (2021). 385O Automated detection of microsatellite status in early colon cancer (CC) using artificial intelligence (AI) integrated infrared (IR) imaging on unstained samples from the AIO ColoPredictPlus 2.0 (CPP) registry study. Annals of Oncology. 32. S531–S532. 1 indexed citations

Moehler, Markus, Annett Maderer, Peter Thuss‐Patience, et al.. (2020). Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER). Annals of Oncology. 31(2). 228–235. 66 indexed citations

Hartmann, J. T., Hans‐Georg Kopp, Viktor Gruenwald, et al.. (2019). Randomised phase II trial of trofosfamide vs. doxorubicin in elderly patients with untreated metastatic soft-tissue sarcoma. European Journal of Cancer. 124. 152–160. 23 indexed citations

Wagner, Dorothea, Heike I. Grabsch, Murielle Mauer, et al.. (2019). EORTC-1203-GITCG - the “INNOVATION”-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group. BMC Cancer. 19(1). 494–494. 87 indexed citations

Reinacher-Schick, A., Dirk Arnold, Nadežda Basara, et al.. (2018). Microsatellite instability is associated with distinct clinical and molecular characteristics in early colon cancer: Analysis of a molecular registry of the AIO colorectal study group - Colopredict Plus. Annals of Oncology. 29. viii174–viii174.

10.

Moehler, Markus, Peter Thuss‐Patience, Baruch Brenner, et al.. (2017). Cisplatin/5-FU (CF) +/- panitumumab (P) for patients (pts) with non-resectable, advanced, or metastatic esophageal squamous cell cancer (ESCC): An open-label, randomized AIO/TTD/BDGO/EORTC phase III trial (POWER).. Journal of Clinical Oncology. 35(15_suppl). 4011–4011. 8 indexed citations

11.

Chekerov, Radoslav, Peter Klare, Petra Krabisch, et al.. (2017). Panitumumab in platinum-sensitive epithelial ovarian cancer patients with KRAS wild-type: The PROVE-study, a phase II randomized multicenter study of the North-Eastern German Society of Gynaecologic Oncology.. Journal of Clinical Oncology. 35(15_suppl). 5558–5558. 6 indexed citations

12.

Wilhelm, Martin, Lothar Mueller, Michael Craig Miller, et al.. (2016). Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice. Clinical Colorectal Cancer. 15(4). 381–388. 54 indexed citations

13.

Rummel, Mathias, Ulrich Kaiser, Christina Balser, et al.. (2015). Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial. The Lancet Oncology. 17(1). 57–66. 110 indexed citations

14.

Kunzmann, Volker, Michael Craig Miller, Stefan Holdenrieder, et al.. (2015). A prospective, multi-center study of individualized, pharmacokinetically (PK)-guided dosing of 5-fluorouracil (5-FU) in metastatic colorectal cancer (mCRC) patients treated with weekly or biweekly 5-FU/oxaliplatin containing regimens.. Journal of Clinical Oncology. 33(15_suppl). 3542–3542. 3 indexed citations

15.

Mueller, Lothar, et al.. (2014). Sequential treatment of advanced or metastatic renal cell carcinoma (mRCC): What is effective? Data from the German RCC registry.. Journal of Clinical Oncology. 32(4_suppl). 499–499. 1 indexed citations

16.

Mueller, Lothar, Uwe Schindler, B.C. Ball, et al.. (2012). Evaluation of soil structure in the framework of an overall soil quality rating. Soil and Tillage Research. 127. 74–84. 89 indexed citations

17.

Mueller, Lothar, Uwe Schindler, T. Graham Shepherd, et al.. (2010). Assessing agricultural soil quality on a global scale. 29–32. 3 indexed citations

18.

Hofheinz, Ralf‐Dieter, Frederik Wenz, Stefan Post, et al.. (2009). Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo-)adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Safety results of a randomized, phase III trial. Journal of Clinical Oncology. 27(15_suppl). 4014–4014. 43 indexed citations

19.

Schindler, Uwe, Lothar Mueller, Frank Eulenstein, & Ralf Dannowski. (2008). A long-term hydrological soil study on the effects of soil and land use on deep seepage dynamics in northeast Germany. Archives of Agronomy and Soil Science. 54(5). 451–463. 6 indexed citations

20.

Schindler, Uwe & Lothar Mueller. (2005). Comparison of deep seepage estimations of a virtual with a real lysimeter by means of TDR-measurements. International Agrophysics. 19(1). 69–73. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact